Science News
from research organizations

New Links In The Cystic Fibrosis Chain Uncover Potential Therapeutics

Date:
October 22, 2007
Source:
Journal of Clinical Investigation
Summary:
Cystic fibrosis is an inherited disease caused by mutations in the CFTR gene. Each mutation has number of effects on lung cells. New in vitro evidence has provided insight into the mechanisms by which one of these changes impacts both CF and the complications of CF, providing support for ongoing clinical trials and raising the possibility of new targets for the development of drugs to treat CF.
Share:
         
Total shares:  
FULL STORY

Cystic fibrosis (CF) is an inherited disease caused by mutations in the CFTR gene. Each mutation has number of effects on the cells of the lungs.

New evidence generated in vitro by Vojo Deretic and colleagues at the University of New Mexico School of Medicine, Albuquerque, has provided insight into the mechanisms by which one of these changes impacts both CF and the complications of CF.

These data provide support for ongoing clinical trials and raise the possibility of new targets for the development of drugs to treat individuals with CF.

CFTR mutations that cause CF make a compartment of the cell known as the TGN more acidic than it is in cells from healthy individuals. In this study, in vitro analysis revealed that hyperacidification of the TGN causes increased activity of a protein known as furin.

Through increased production of a soluble factor known as TGF-beta this augmented the production of collagen (which in situ is associated with tissue fibrosis, a characteristic of damaged lung in individuals with CF) and suppressed the ability of human macrophages to kill the bacterium Pseudomonas aeruginosa, infection with which is a major complication for individuals with CF.

This study provides strong support for the use of chloroquine (which counteracts high levels of TGN acidity) to treat CF, something that is currently being tested in clinical trials, and identifies furin inhibitors as potential new therapeutics for the treatment of CF.

Article:  Elevated furin levels in human cystic fibrosis cells result in hypersusceptibility to exotoxin A-induced cytotoxicity


Story Source:

The above story is based on materials provided by Journal of Clinical Investigation. Note: Materials may be edited for content and length.


Cite This Page:

Journal of Clinical Investigation. "New Links In The Cystic Fibrosis Chain Uncover Potential Therapeutics." ScienceDaily. ScienceDaily, 22 October 2007. <www.sciencedaily.com/releases/2007/10/071018171450.htm>.
Journal of Clinical Investigation. (2007, October 22). New Links In The Cystic Fibrosis Chain Uncover Potential Therapeutics. ScienceDaily. Retrieved April 27, 2015 from www.sciencedaily.com/releases/2007/10/071018171450.htm
Journal of Clinical Investigation. "New Links In The Cystic Fibrosis Chain Uncover Potential Therapeutics." ScienceDaily. www.sciencedaily.com/releases/2007/10/071018171450.htm (accessed April 27, 2015).

Share This Page:


Health & Medicine News
April 27, 2015

Latest Headlines
updated 12:56 pm ET